This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

CG WG Call Notes leading to 2016 January WGM

From HL7Wiki
Jump to navigation Jump to search

October 20, 2015 -- Weekly call

Agenda

  • 5 min Updates from
    • ClinGen
    • GA4GH
    • IOM
    • other?
  • Atlanta WGM review
    • minutes
  • "HL7 v2 genomics report lite"
  • Orlando WGM - room reservation
  • Oct 23 deadline
  • FHIR review (Gil)
  • Upcoming deadlines:
    • 2015-10-23: Deadline to complete the Post-WGM Evaluation (WG Health metric)
    • 2015-10-23: Deadline to complete WGM Room Request form for the January WGM (WG Health metric)
    • 2015-10-23: Deadline to post your October WGM minutes on the website or wiki (WG Health metric)
    • 2015-10-23: Deadline to notify HQ of additions/changes/corrections to Co-Chair openings
    • 2015-10-25: Notification of Intent to Ballot (NIB) Deadline
    • 2015-10-26: Initial Harmonization proposals due
    • 2015-10-28: Co-Chair Nominations Open

Attendees

  • Amnon Shabo (Shvo), Siew Lam, Jon Holt, Gil Alterovitz, Grant Wood, Anwar, Bob Freimuth, Bret, Heale, Clem Mcdonald, David Kreda, Eric Whitebay, JD Nolen, Kevin Power, Mollie (joined after 30 minutes)

Draft Minutes

  • Jon gave an update on structured variants (Cytogenetics) in ClinGen
  • Grant gave an update on GA4GH, in particular on the effort related to family health history, and how FHH can be incorporated to the EHR
  • Gil gave an update on FHIR activities
  • Grant abnd JD gave an update on the EHR and genomics group
  • Bob Milius gave an overview of the Atlanta WGM discussions
  • Amnon commented on the FHIR discussion that if we can introduce a base resource to FHIR it should be the Genetic Observation Profile (with possible refinements) and then Sequence becomes a profile over the base Genetic Observation Resource. The rationale is that Sequence is a type of genetic observation so that the natural hierarchy.
  • Gil gave an update on FHIR activities
  • Mollie made a motion to have Gil designated as the CG rep. to FHIR ('group lead')
  • Jon asked about the exact role of FHIR rep.
  • Bob M. suggested we should have full transparency in the relations with FHIR
    • Motion passed